doi: 10.1016/j.vaccine.2021.03.077.
Epub 2021 Mar 26.
The development of COVID-19 vaccines in the United States: Why and how so fast?
Affiliations
- PMID: 33824043
- PMCID: PMC7997594
- DOI: 10.1016/j.vaccine.2021.03.077
Item in Clipboard
The development of COVID-19 vaccines in the United States: Why and how so fast?
Vaccine.
.
No abstract available
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
The race to make a COVID-19 vaccine.Lancet. 2021 Sep 4;398(10303):832-833. doi: 10.1016/S0140-6736(21)01902-4. Lancet. 2021. PMID: 34481566 Free PMC article. No abstract available.
-
Fast Development of High-Quality Vaccines in a Pandemic.Chest. 2021 Jul;160(1):e1-e3. doi: 10.1016/j.chest.2021.03.063. Epub 2021 Apr 20. Chest. 2021. PMID: 33848535 Free PMC article. No abstract available.
-
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34437519 Free PMC article.
-
Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.J Microbiol Biotechnol. 2020 Aug 28;30(8):1109-1115. doi: 10.4014/jmb.2006.06006. J Microbiol Biotechnol. 2020. PMID: 32627758 Free PMC article. Review.
-
Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19.Hum Vaccin Immunother. 2020 Dec 1;16(12):3055-3060. doi: 10.1080/21645515.2020.1796425. Epub 2020 Aug 26. Hum Vaccin Immunother. 2020. PMID: 32845733 Free PMC article. Review.
Cited by
-
A statistical look at the COVID-19 vaccine development and vaccine policies.Front Public Health. 2022 Dec 5;10:1048062. doi: 10.3389/fpubh.2022.1048062. eCollection 2022. Front Public Health. 2022. PMID: 36544793 Free PMC article.
-
Artificial intelligence and clinical data suggest the T cell-mediated SARS-CoV-2 nonstructural protein intranasal vaccines for global COVID-19 immunity.Vaccine. 2022 Jul 30;40(32):4296-4300. doi: 10.1016/j.vaccine.2022.06.052. Epub 2022 Jun 24. Vaccine. 2022. PMID: 35778279 Free PMC article.
-
De-risking vaccine development: lessons, challenges, and prospects.NPJ Vaccines. 2025 Jul 30;10(1):177. doi: 10.1038/s41541-025-01211-z. NPJ Vaccines. 2025. PMID: 40739092 Free PMC article. Review.
-
Geospatial analysis of contagious infection growth and cross-boundary transmission in non-vaccinated districts of North-East Indian states during the COVID-19 pandemic.Lancet Reg Health Southeast Asia. 2024 Jul 19;28:100451. doi: 10.1016/j.lansea.2024.100451. eCollection 2024 Sep. Lancet Reg Health Southeast Asia. 2024. PMID: 39155937 Free PMC article.
-
Safety Profiles of mRNA COVID-19 Vaccines Using World Health Organization Global Scale Database (VigiBase): A Latent Class Analysis.Infect Dis Ther. 2023 Feb;12(2):443-458. doi: 10.1007/s40121-022-00742-5. Epub 2022 Dec 15. Infect Dis Ther. 2023. PMID: 36520333 Free PMC article.
References
-
- Calloway E. The race for coronavirus vaccines. Nature. 2020;580:576–577. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
